Latest News

• Alert FDA OKs First Contact Lens to Slow Myopia in Children MiSight (CooperVision Inc) soft, disposable contact lenses are meant to be worn daily (but not overnight) to correct nearsightedness and slow the progression of myopia in children 8 to 12 years old.
  FDA Approvals, November 18, 2019
• Positive Top-line Results for Novel Agent in Acute Psychosis KarXT combines xanomeline and trospium and is designed to treat psychosis and related symptoms through preferential stimulation of muscarinic receptors in the central nervous system.
  Medscape Medical News, November 18, 2019
• Fluoride at High Levels 'Presumed' a Neurodevelopmental Hazard The National Toxicology Program found a link between high fluoride exposure in children and cognitive impairment, according to a draft report and systematic review.
  Medscape Medical News, November 18, 2019
• KidneyWeek 2019Older Immunosuppressant as Good As Newer One, But 10 Times Cheaper Replacement of azathioprine with mycophenolate mofetil for kidney transplantation was a very costly move, with no discernible benefits in the era of modern immunosuppression, say authors of ATHENA.
  Medscape Medical News, November 18, 2019
• 'Hyperpalatable' Defined as Foods Driving the Obesity Epidemic "We believe that one of the drivers of the obesity epidemic is ready access to energy dense, hyperpalatable foods," says an expert. Having a standard, universal definition is therefore key.
  Medscape Medical News, November 18, 2019
• AHA 2019Sacubitril/Valsartan Benefits Extend to HF With Mildly Reduced EF Further analysis of the PARAGON trial also suggest the benefit of the drug combination may reach higher ejection fractions in women.
  Medscape Medical News, November 17, 2019
• AHA 2019ISCHEMIA: PCI, Surgery Strike Out vs Meds The $100 million trial signals that not every stable patient with stable, moderate-to-severe ischemic disease needs to go to the cath lab, and will not suffer as a result.
  Medscape Medical News, November 16, 2019
• Asthma Prescribing Choice Affects Greenhouse Gas Emissions For every 10% of metered-dose inhalers replaced with dry powder inhalers, greenhouse gas emissions could be reduced and millions of dollars per year could be saved as well, a study found.
  Medscape Medical News, November 15, 2019
• Alert FDA OKs Crizanlizumab, Targeted Therapy for Sickle Cell Crisis Crizanlizumab binds to P-selectin, a cell adhesion protein that plays a central role in the multicellular interactions that can lead to vaso-occlusion in sickle cell disease.
  FDA Approvals, November 15, 2019
• New AHA/ACC Performance and Quality Statement on Hypertension Hypertension affects more than one third of US adults, but achieving adequate control remains elusive. A new document fine-tunes existing approaches and suggests new strategies.
  Medscape Medical News, November 15, 2019
• Virginia Ob-Gyn Accused of 'Deeply Disturbing' Unneeded Surgeries The physician is also accused of removing a woman's fallopian tubes without her knowledge. A prosecutor says 173 women have come forward since his arrest reporting similar unwanted procedures.
  Medscape Medical News, November 15, 2019
• HHS Kicks Off Battle for More Price Transparency in Healthcare CMS intends to use regulations to force more disclosure of prices. The agency expects this would foster development of more online tools to help consumers shop for medical care.
  Medscape Medical News, November 15, 2019
• IVF Add-Ons Don't Improve Birth Rates Multiple reviews find IVF add-ons are on the market without sufficient evidence they improve the odds of having a baby.
  Medscape Medical News, November 15, 2019
• Alert EMA Panel Endorses Polatuzumab for Diffuse Large B-Cell Lymphoma The Committee for Medicinal Products for Human Use recommended marketing approval of the drug for treatment of relapsed/refractory disease.
  Medscape Medical News, November 15, 2019
• Lavender Promising for Anxiety but Evidence Base Needs to Grow Lavender may have a role in treating anxiety, but no firm conclusions can be drawn without higher quality, less biased studies, a large systematic review and meta-analysis suggests.
  Medscape Medical News, November 15, 2019
• KidneyWeek 2019Osteoporosis Screening Often Missed in Patients With ESRD Women with ESRD on hemodialysis are rarely screened for osteoporosis despite the fact they are at high risk for bone diseases compared with the general population.
  Medscape Medical News, November 15, 2019
• Alert FDA OKs New Antibacterial Cefiderocol for Complicated UTI Last month, an FDA panel recommended approval of cefiderocol for treatment of complicated urinary tract infections (cUTIs), including pyelonephritis caused by Gram-negative bacteria.
  FDA Approvals, November 15, 2019
• Lung Cancer Progress: Survival Increasing in US More people are now alive 5 years after being diagnosed with lung cancer than a decade ago, but the incidence of and mortality from lung cancer varies widely across the United States.
  Medscape Medical News, November 15, 2019
• Confusion as EU Advice on Vaginal Estradiol Differs from US The European Medicines Agency recommends restricting use of "high-strength" estradiol creams to 4 weeks; the US FDA requires a boxed warning on all estradiol label.
  Medscape Medical News, November 15, 2019
• Alert FDA Panel Recommends High-Dose EPA for CV Event Reduction Icosapent ethyl (Vascepa, Amarin) was unanimously recommended for approval as an adjunct to statin therapy. However, the exact population for whom the drug should be prescribed was not decided.
  News Alerts, November 14, 2019